David Roberge
Overview
Explore the profile of David Roberge including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
146
Citations
4484
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Guillemette A, Roberge D, Menard C, Bahary J, Bou Assi E, Nguyen D, et al.
Can J Neurol Sci
. 2025 Mar;
:1-22.
PMID: 40026079
No abstract available.
2.
Gondi V, Deshmukh S, Brown P, Wefel J, Armstrong T, Tome W, et al.
Int J Radiat Oncol Biol Phys
. 2025 Jan;
121(2):571-572.
PMID: 39824575
No abstract available.
3.
Litvinov I, Abu-Hilal M, Alhusayen R, Delisle B, Dutz J, Guenin S, et al.
Front Med (Lausanne)
. 2024 Dec;
11:1474030.
PMID: 39736968
Mycosis fungoides (MF) is the most common type of cutaneous T-cell lymphoma (CTCL), representing the majority of all lymphomas arising in the skin. The disease treatment focuses on managing symptoms...
4.
Rayn K, Magliari A, Clark R, Rosa L, Doucet R, Comeau L, et al.
Front Oncol
. 2024 Dec;
14:1465171.
PMID: 39664187
Introduction: This study develops two new multi-institutional hippocampal-sparing whole-brain RapidPlan™ models (HLS-EC-WB and HMS-EC-WB) inspired by CCTG-CE.7 featuring enhanced target coverage with varying hippocampal sparing (limited and moderate). Methods: New...
5.
Miller C, Lecavalier-Barsoum M, Ma K, Santos Dutra M, Kaitoukov Y, Bahoric B, et al.
Endosc Int Open
. 2024 Oct;
12(10):E1085-E1091.
PMID: 39398444
Pancreatic cancer is a devastating disease with limited locoregional treatment options. Diffusing alpha-emitter radiation therapy (Alpha DaRT), a novel cancer treatment using alpha-particle interstitial radiotherapy, may help address this challenge....
6.
Darsaut T, Gentric J, Heppner J, Lopez C, Jabre R, Iancu D, et al.
J Neurosurg
. 2024 Oct;
142(3):637-646.
PMID: 39393100
Objective: Many patients recruited in the Treatment of Brain Arteriovenous Malformations Study (TOBAS) are managed conservatively. The aim of this study was to monitor what happened to those patients. Methods:...
7.
Dawson L, Ringash J, Fairchild A, Stos P, Dennis K, Mahmud A, et al.
Lancet Oncol
. 2024 Sep;
25(10):1337-1346.
PMID: 39245060
Background: Palliative treatment options for painful hepatic cancer can be restricted due to patients eventually becoming refractory to standard treatment. The aim of this study was to determine whether radiotherapy...
8.
Zhang S, Simard M, Lapointe A, Filion E, Campeau M, Vu T, et al.
Int J Radiat Oncol Biol Phys
. 2024 May;
120(3):894-903.
PMID: 38705488
Purpose: There is interest in using dual-energy computed tomography (DECT) to evaluate organ function before and after radiation therapy (RT). The purpose of this study (trial identifier: NCT04863027) is to...
9.
Berg M, Popradi G, Roberge D, Petrogiannis-Haliotis T, Pehr K
J Cutan Med Surg
. 2024 Jan;
28(1):29-32.
PMID: 38229268
Background: Skin diseases have been shown to worsen psychological distress, which, in turn, may be detrimental to treatment outcomes. Both the impact of psychological distress on response to treatment in...
10.
Li H, Mayr N, Griffin R, Zhang H, Pokhrel D, Grams M, et al.
Int J Radiat Oncol Biol Phys
. 2023 Dec;
119(3):737-749.
PMID: 38110104
Purpose: The highly heterogeneous dose delivery of spatially fractionated radiation therapy (SFRT) is a profound departure from standard radiation planning and reporting approaches. Early SFRT studies have shown excellent clinical...